Form 4: Fulgent Genetics CEO's Tax Withholding on RSU Vesting

Fulgent Genetics CEO Ming Hsieh reported the withholding of 2,944 shares to cover tax obligations from restricted stock unit vesting.

Summary

• Ming Hsieh, Chief Executive Officer, Director, and 10% Owner of Fulgent Genetics, Inc. (FLGT), reported a transaction on August 26, 2025.
• 2,944 shares of Common Stock were disposed of (withheld) at a price of $21.47 per share.
• The shares were withheld to satisfy tax withholding obligations arising from the vesting of restricted stock units (RSUs) granted on February 26, 2024.
• Following the transaction, Mr. Hsieh directly beneficially owns 804,281 shares of Common Stock.
• Indirect beneficial ownership includes 7,895,115 shares held by the Dynasty Trust, 220,816 shares by The Ming Hsieh Trust, and 2,000 shares across two Uniform Transfer to Minor Accounts.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary insider transaction (tax withholding on RSU vesting), which is neutral in terms of company performance or executive sentiment towards the stock.

Positives

• The transaction stems from the vesting of restricted stock units, indicating the fulfillment of compensation agreements and continued executive tenure.
• The vesting of RSUs is a positive event for the executive, representing earned compensation.

Negatives

• A total of 2,944 shares were disposed of, reducing Mr. Hsieh's direct beneficial ownership.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction related to executive compensation and does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction related to executive compensation, not an open market sale driven by investment conviction.
• Employees: The vesting of RSUs is a standard component of executive compensation, reflecting ongoing employment and performance.

Key Dates

Recommendation

The filing details a routine tax withholding event related to restricted stock unit vesting for the CEO. This is a non-discretionary transaction and does not reflect a change in the executive's investment conviction or the company's fundamental performance, thus warranting a 'hold' recommendation based solely on this filing.

Keywords

Fulgent Genetics, FLGT, Ming Hsieh, CEO, Form 4, insider transaction, RSU vesting, tax withholding, beneficial ownership